Close

VOLUNTARY ANNOUNCEMENT - BIOLOGICS LICENSE APPLICATION OF RISVUTATUG REZETECAN FOR INJECTION (HS-20093) FOR OSTEOSARCOMA ACCEPTED BY THE NMPA

Attachments

HKEX-EPS_20260924_12345892_0.PDF